Phase 2 trial of concurrent 5‐fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity‐modulated radiation therapy for locally advanced head and neck cancer (Q33391825)
Jump to navigation
Jump to search
scientific article published on September 9, 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase 2 trial of concurrent 5‐fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity‐modulated radiation therapy for locally advanced head and neck cancer |
scientific article published on September 9, 2010 |
Statements
1 reference
Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer (English)
1 reference
Phase 2 trial of concurrent 5‐fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity‐modulated radiation therapy for locally advanced head and neck cancer (English)
1 reference
Johnny Kao
1 reference
Vishal Gupta
1 reference
Michael Rivera
1 reference
Vivek Gurudutt
1 reference
Marita Teng
1 reference
Eric M. Genden
Edelweiss L. Policarpio
Ryan J. Burri
Peter M. Som
9 September 2010
1 reference
1 reference
1 reference
117
1 reference
318-326
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference